| pubmed-article:8470060 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0015491 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0006556 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0332256 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C1527177 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0441513 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C1514926 | lld:lifeskim |
| pubmed-article:8470060 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:8470060 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8470060 | pubmed:dateCreated | 1993-5-12 | lld:pubmed |
| pubmed-article:8470060 | pubmed:abstractText | We constructed a new factor IX expression vector containing a full length factor IX cDNA. The Moloney Murine Leukemia Virus (MoMLV)-based retroviral vector pLRNL was cloned with the entire coding region of human factor IX down stream of the promoter of Rous sarcoma virus, giving rise to the construct pL9RNL. The GP+E 86 packaging cell was transfected with pL9RNL and two mouse fibroblast cell lines (PA317 and NIH3T3) were infected with the virus generated from PA317 cell. During the 24 hr culture period, the maximum 1.2 micrograms of factor IX was secreted into the medium from 10(6) of GP+E 86 cells. Factor IX in the culture media had the relatively normal procoagulant activity and was barium-citrate precipitated. Western blotting analysis of the barium-citrate precipitates revealed that a single chain 50Kd protein indistinguishable from the plasma-derived factor IX was produced in these three cells. The retroviral expression system that we utilized herein may contribute to the study of recombinant wild type or various mutant factor IX, and to the basic study for the future gene therapy. | lld:pubmed |
| pubmed-article:8470060 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8470060 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8470060 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8470060 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8470060 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8470060 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8470060 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8470060 | pubmed:issn | 0049-3848 | lld:pubmed |
| pubmed-article:8470060 | pubmed:author | pubmed-author:SaitoHH | lld:pubmed |
| pubmed-article:8470060 | pubmed:author | pubmed-author:MatsushitaTT | lld:pubmed |
| pubmed-article:8470060 | pubmed:author | pubmed-author:TakamatsuJJ | lld:pubmed |
| pubmed-article:8470060 | pubmed:author | pubmed-author:TakahashiII | lld:pubmed |
| pubmed-article:8470060 | pubmed:author | pubmed-author:FONJJ | lld:pubmed |
| pubmed-article:8470060 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8470060 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8470060 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:8470060 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8470060 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8470060 | pubmed:pagination | 387-93 | lld:pubmed |
| pubmed-article:8470060 | pubmed:dateRevised | 2006-4-21 | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:meshHeading | pubmed-meshheading:8470060-... | lld:pubmed |
| pubmed-article:8470060 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8470060 | pubmed:articleTitle | Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA. | lld:pubmed |
| pubmed-article:8470060 | pubmed:affiliation | First Department of Internal Medicine, Nagoya University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:8470060 | pubmed:publicationType | Journal Article | lld:pubmed |
